Segal J - Search Results

1

Tissue factor activity in patients with systemic lupus erythematosus: association with disease activity.

Segal J, Kickler T, Petri M. Segal J, et al. J Rheumatol. 2000 Dec;27(12):2827-32. J Rheumatol. 2000. PMID: 11128671

2

Coagulation markers predicting cardiac transplant rejection.

Segal JB, Kasper EK, Rohde C, Bray PF, Baldwin WM 3rd, Resar JR, Hruban RH, Kickler TS. Segal JB, et al. Transplantation. 2001 Jul 27;72(2):233-7. doi: 10.1097/00007890-200107270-00011. Transplantation. 2001. PMID: 11477344

3

Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection.

Chance JJ, Segal JB, Wallerson G, Kasper E, Hruban RH, Kickler TS, Chan DW. Chance JJ, et al. Among authors: segal jb. Clin Chim Acta. 2001 Oct;312(1-2):31-9. doi: 10.1016/s0009-8981(01)00590-3. Clin Chim Acta. 2001. PMID: 11580907

4

Usefulness of decreased levels of D-dimer in predicting progressive accelerated graft arteriosclerosis.

Hennebry TA, Segal JB, Kickler TS, Kasper EK, Resar JR. Hennebry TA, et al. Am J Cardiol. 2002 Apr 1;89(7):884-7. doi: 10.1016/s0002-9149(02)02209-9. Am J Cardiol. 2002. PMID: 11909583 No abstract available.

5

Testing strategies for diagnosing lupus anticoagulant: decision analysis.

Segal JB, Lehmann HP, Petri M, Mueller L, Kickler TS. Segal JB, et al. Am J Hematol. 2002 Jul;70(3):195-205. doi: 10.1002/ajh.10115. Am J Hematol. 2002. PMID: 12111765 Free article.

6

Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism.

Brotman DJ, Segal JB, Jani JT, Petty BG, Kickler TS. Brotman DJ, et al. Among authors: segal jb. Am J Med. 2003 Mar;114(4):276-82. doi: 10.1016/s0002-9343(02)01520-6. Am J Med. 2003. PMID: 12681454

7

ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.

Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG. Streiff MB, et al. Among authors: segal j. Cancer. 2004 Apr 15;100(8):1717-23. doi: 10.1002/cncr.20150. Cancer. 2004. PMID: 15073862 Free article.

8

Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization.

Gluckman TJ, Segal JB, Fredde NL, Saland KE, Jani JT, Walenga JM, Prechel MM, Citro KM, Zidar DA, Fox E, Schulman SP, Kickler TS, Rade JJ. Gluckman TJ, et al. Among authors: segal jb. Am J Cardiol. 2005 Mar 15;95(6):744-7. doi: 10.1016/j.amjcard.2004.11.026. Am J Cardiol. 2005. PMID: 15757601

9

Heparin-induced antibodies and cardiovascular risk in patients on dialysis.

Asmis LM, Segal JB, Plantinga LC, Fink NE, Kerman JS, Kickler TS, Coresh J, Gardner LB. Asmis LM, et al. Among authors: segal jb. Thromb Haemost. 2008 Sep;100(3):498-504. Thromb Haemost. 2008. PMID: 18766268 Free article.

10

Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.

Gluckman TJ, Segal JB, Schulman SP, Shapiro EP, Kickler TS, Prechel MM, Conte JV, Walenga JM, Shafique I, Rade JJ. Gluckman TJ, et al. Among authors: segal jb. J Thromb Haemost. 2009 Sep;7(9):1457-64. doi: 10.1111/j.1538-7836.2009.03526.x. Epub 2009 Jun 23. J Thromb Haemost. 2009. PMID: 19552638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,079 results

Search Page

Filters